Masimo (MASI) Return on Capital Employed Growth (3y) (2013 - 2026)
Masimo (MASI) Return on Capital Employed Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.14 Bn | 173.84 Bn | 6.27 Bn | -1,679.00 |
| 2 | Stryker | 128.35 Bn | 125.47 Bn | 3.81 Bn | 214.00 |
| 3 | Medtronic | 107.95 Bn | 98.73 Bn | 6.41 Bn | 145.00 |
| 4 | Boston Scientific | 68.16 Bn | 66.71 Bn | 3.61 Bn | 355.00 |
| 5 | Edwards Lifesciences | 47.67 Bn | 44.00 Bn | 1.29 Bn | -846.00 |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn | -247.00 |
| 7 | Dexcom | 28.45 Bn | 27.33 Bn | 750.30 Mn | 1,318.00 |
| 8 | Smith & Nephew | 26.83 Bn | 26.25 Bn | - | - |
| 9 | Koninklijke Philips | 25.36 Bn | 22.23 Bn | 2.07 Bn | - |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn | 1,268.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 1,268.00 |
| Jan 3, 2026 | 1,086.00 |
| Sep 27, 2025 | 11.00 |
| Jun 28, 2025 | -576.00 |
| Mar 29, 2025 | -1,183.00 |
| Dec 28, 2024 | -1,488.00 |
| Sep 28, 2024 | -881.00 |
| Jun 29, 2024 | -985.00 |
| Mar 30, 2024 | -1,006.00 |
| Dec 30, 2023 | -1,053.00 |
| Sep 30, 2023 | -746.00 |
| Jul 1, 2023 | -744.00 |
| Apr 1, 2023 | -801.00 |
| Dec 31, 2022 | -720.00 |
| Oct 1, 2022 | -1,020.00 |
| Jul 2, 2022 | -766.00 |
| Apr 2, 2022 | -368.00 |
| Jan 1, 2022 | -357.00 |
| Oct 2, 2021 | -430.00 |
| Jul 3, 2021 | -478.00 |